Listed

U S Physical Therapy Inc: Form 10-Q for the period ended Jun 30, 2013

Filed with the SEC on Aug 8, 2013 and accepted by EDGAR at Aug 8, 2013, 08:03 ET.

Share

Management's discussion and analysis

As filed, 29,703 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

EXECUTIVE SUMMARY

Our Business

We operate outpatient physical therapy clinics that provide preventive and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. As of June 30, 2013, we operated 449 clinics in 43 states, including one physician services facility.

We also manage physical therapy facilities for third parties, primarily physicians, with 17 third-party facilities under management as of June 30, 2013.

We also derived revenues from physician services which are generated by franchise arrangements and fees with third parties and through one physician services facility. The franchise arrangements contain multiple deliverables - training and ongoing services. Each component can be purchased separately.

In November 2007, we formed a new venture, OsteoArthritis Centers of America, LP (“OA Centers”), and initially opened two locations. The business specializes in the outpatient, non-surgical treatment of osteo arthritis, degenerative joint disease and other musculoskeletal conditions. In October 2008, we acquired a 65% interest in Rehab Management Group (“RMG”). RMG provides physicians and their patients with clinical services including electro-diagnostic analysis (“EDX”) as well as intra articular joint (“IAJP Direct”) and lumbar osteoarthritis (“LOP Direct”) programs. The operations of OA Centers and RMG are referred to as our “Physician Services Business”.

In 2012, and through the first six months of 2013, the margin from the Physician Services Business was negative. See Gross Margin discussions below.

In the first quarter of 2013, we made a management change to oversee the Physician Services Business. In December 2012, we closed one of the OA Centers and will close the second location in late August 2013. We expect to incur approximately $50,000 in cost in August 2013 related to the OA Center closure. In the event that we are unsuccessful in returning the RMG part of the Physician Services Business to former levels of profitability, we may be required to write-down a portion of or all of the goodwill and other intangible assets associated with RMG. As of June 30, 2013, the goodwill and other intangible assets of RMG were valued at $6.4 million.

During the six months ended June 30, 2013, we acquired the following physical therapy clinic groups:

Acquisition Date % Interest Acquired Number of Clinics
February 2013 Acquisition Feb 28 72% 9
April 2013 Acquisition Apr 30 50% 5
May 2013 Acquisition May 24 80% 5

In addition to the above clinic groups, we acquired, through two of our subsidiaries, two physical therapy clinics in two separate transactions during the six months ended June 30, 2013 - one in February and one in June (the “Tuck-In Acquisitions).

The results of operations of the acquired clinics have been included in our consolidated financial statements since the date of their acquisition.

Selected Operating and Financial Data

The following table presents selected operating and financial data that we believe are key indicators of our operating performance.

For the Three Months Ended June 30, 2013 2012 For the Six Months Ended June 30, 2013 2012
Number of clinics, at the end of period 449 419 449 419
Working days 64 64 127 128
Average visits per day per clinic 21.6 22.1 21.3 21.9
Total patient visits 614,241 587,324 1,192,116 1,165,994
Net patient revenue per visit $106.30 $105.65 $106.37 $105.10

RESULTS OF OPERATIONS

Three Months Ended June 30, 2013 Compared to the Three Months Ended June 30, 2012

  • Net revenues increased to $67.2 million for the three months ended June 30, 2013 (“2013 Second Quarter”) from $64.0 million for the three months ended June 30, 2012 (“2012 Second Quarter”) primarily due to an increase in visits of 27,000 from 587,000 for the 2012 Second Quarter to 614,000 for the 2013 Second Quarter and an increase in the average net patient revenue per visit for the 2013 Second Quarter to $106.30 from $105.65 in the 2012 Second Quarter.
  • Net income attributable to our common shareholders for the 2013 Second Quarter was $4.9 million versus $4.8 million for the 2012 Second Quarter. Net income was $0.41 per diluted share for both periods. Total diluted shares were 12.1 million for the 2013 Second Quarter and 11.9 million for the 2012 Second Quarter.

Net Patient Revenues

  • Net patient revenues increased to $65.3 million for the 2013 Second Quarter from $62.1 million for the 2012 Second Quarter, an increase of $3.2 million, or 5.2%, due to an increase in visits, due to clinics opened and acquired between July 1, 2012 and June 30, 2013 (“New Clinics”), and an increase in the net patient revenue per visit of $0.65.
  • Net patient revenues related to New Clinics amounted to $3.6 million for the 2013 Second Quarter and net patient revenues for clinics opened or acquired prior to July 1, 2012 (“Mature Clinics”) decreased by $0.4 million for the 2013 Second Quarter as compared to the 2012 Second Quarter. Patient visits for Mature Clinics in the 2013 Second Quarter were 6,400 less than in the 2012 Second Quarter.

Net patient revenues are based on established billing rates less allowances and discounts for patients covered by contractual programs and workers’ compensation. Net patient revenues are determined after contractual and other adjustments relating to patient discounts from certain payors. Payments received under these programs are based on predetermined rates and are generally less than the established billing rates.

Other Revenues

Other revenues remained relatively the same for both periods.

Clinic Operating Costs

Clinic operating costs as a percentage of net revenues were 74.3% for the 2013 Second Quarter and 73.4% for the 2012 Second Quarter.

Clinic Operating Costs - Salaries and Related Costs

Salaries and related costs increased to $35.8 million for the 2013 Second Quarter from $32.7 million for the 2012 Second Quarter, an increase of $3.1 million, or 9.6%. Salaries and related costs for New Clinics amounted to $2.3 million for the 2013 Second Quarter. Salaries and related costs for Mature Clinics increased by $0.8 million for the 2013 Second Quarter as compared to the 2012 Second Quarter. The increase in salaries and related costs for Mature Clinics is due to the results of the acquisition of a 7 clinic group in May of 2012 (“May 2012 Acquisition). The 2013 Second Quarter includes three months of activity, and the 2012 Second Quarter includes slightly over one month of activity, for the May 2012 Acquisition. Salaries and related costs as a percentage of net revenues were 53.3% for the 2013 Second Quarter and 51.1% for the 2012 Second Quarter.

Clinic Operating Costs - Rent, Clinic Supplies, Contract Labor and Other

Rent, clinic supplies, contract labor and other were $12.9 million for the 2013 Second Quarter and $13.0 million for the 2012 Second Quarter. For New Clinics, rent, clinic supplies, contract labor and other amounted to $0.9 million for the 2013 Second Quarter. For Mature Clinics, rent, clinic supplies, contract labor and other decreased by $1.0 million in the 2013 Second Quarter compared to the 2012 Second Quarter. Rent, clinic supplies, contract labor and other as a percentage of net revenues was 19.2% for the 2013 Second Quarter and 20.3% for the 2012 Second Quarter.

Clinic Operating Costs - Provision for Doubtful Accounts

The provision for doubtful accounts was $1.2 million for the 2013 Second Quarter and $1.3 million for the 2012 Second Quarter. The provision for doubtful accounts for patient accounts receivable as a percentage of net patient revenues was 1.8% for the 2013 Second Quarter and 2.1% for the 2012 Second Quarter.

Our allowance for doubtful accounts for patient accounts receivable as a percentage of total patient accounts receivable was 5.1% at June 30, 2013, as compared to 5.8% at December 31, 2012. Our days sales outstanding was 40 days at June 30, 2013 and 42 days at December 31, 2012.

Gross Margin

The following table details the gross margin derived from our core physical therapy business and physician services business for the 2013 Second Quarter and 2012 Second Quarter (in thousands):

Three Months Ended June 30, 2013 2012
Gross margin - physical therapy services $17,586 $17,140
Gross margin - physician services (280) (146)
Gross margin $17,306 $16,994

In the first quarter of 2013, we made a management change to oversee the Physician Services Business. In December 2012, we closed one of the OA Centers and will close the second location in late August 2013. We expect to incur approximately $50,000 in cost in August 2013 related to the OA Center closure. In the event that we are unsuccessful in returning the RMG part of the Physician Services Business to former levels of profitability, the Company may be required to write-down a portion of or all of the goodwill and other intangible assets associated with RMG. As of June 30, 2013, the goodwill and other intangible assets of RMG were valued at $6.4 million.

Corporate Office Costs

Corporate office costs, consisting primarily of salaries and benefits of corporate office personnel, rent, insurance costs, depreciation and amortization, travel, legal, professional, and recruiting fees, were $6.6 million for the 2013 Second Quarter and $6.4 million for the 2012 Second Quarter. As a percentage of net revenues, corporate office costs were 9.9% for the 2013 Second Quarter and 10.0% for the 2012 Second Quarter.

Interest Expense

Interest expense decreased to $130,000 in the 2013 Second Quarter compared to $145,000 in the 2012 Second Quarter due to a lower average outstanding balance under the Credit Agreement during the 2013 period compared to the 2012 period. At June 30, 2013, $15,750,000 was outstanding under our Credit Agreement.

Provision for Income Taxes

The provision for income taxes was $3.2 million for the 2013 Second Quarter and $3.1 million for the 2012 Second Quarter. During the 2013 and 2012 Second Quarters, we accrued state and federal income taxes at an effective tax rate (provision for taxes divided by the difference between income before taxes and net income attributable to non-controlling interests) of 39.3%.

Non-controlling Interests

Net income attributable to non-controlling interests was $2.5 million for the 2013 Second Quarter and for the 2012 Second Quarter. Net income attributable to non-controlling interests as a percentage of operating income before corporate office costs was 14.2% for the 2013 Second Quarter and 14.5% for the 2012 Second Quarter.

Six Months Ended June 30, 2013 Compared to the Six Months Ended June 30, 2012

  • Net revenues increased to $130.3 million for the Six Months ended June 30, 2013 (“2013 First Six Months”) from $126.5 million for the Six Months ended June 30, 2012 (“2012 First Six Months”) primarily due to an increase in visits of 26,000 from 1,166,000 for the 2012 First Six Months to 1,192,000 for the 2013 First Six Months and an increase in the average net patient revenue per visit for the 2013 First Six Months to $106.37 from $105.10 in the 2012 First Six Months.
  • Net income attributable to our common shareholders for the 2013 First Six Months was $8.6 million versus $9.3 million for the 2012 First Six Months. Net income was $0.72 per diluted share for the 2013 First Six Months compared to $0.79 for the 2012 First Six Months. Total diluted shares were 12.0 million for the 2013 First Six Months and 11.9 million for the 2012 First Six Months.

Net Patient Revenues

  • Net patient revenues increased to $126.8 million for the 2013 First Six Months from $122.6 million for the 2012 First Six Months, an increase of $4.2 million, or 3.5%, due to an increase in visits, due to New Clinics, and an increase in the net patient revenue per visit of $1.27.
  • Net patient revenues related to New Clinics amounted to $5.1 million for the 2013 First Six Months and net patient revenues for Mature Clinics decreased by $0.9 million for the 2013 First Six Months as compared to the 2012 First Six Months. Patient visits for Mature Clinics in the 2013 First Six Months were 20,800 less than in the 2012 First Six Months.

Net patient revenues are based on established billing rates less allowances and discounts for patients covered by contractual programs and workers’ compensation. Net patient revenues are determined after contractual and other adjustments relating to patient discounts from certain payors. Payments received under these programs are based on predetermined rates and are generally less than the established billing rates.

Other Revenues

Other revenues were $3.5 million for the 2013 First Six Months compared to $4.0 million for the 2012 First Six Months. The decrease of $0.5 million was due to reduced revenues in the RMG part of the Physician Services Business. See Gross Margin discussion below.

Clinic Operating Costs

Clinic operating costs as a percentage of net revenues were 75.5% for the 2013 First Six Months and 73.8% for the 2012 First Six Months.

Clinic Operating Costs - Salaries and Related Costs

Salaries and related costs increased to $70.2 million for the 2013 First Six Months from $65.5 million for the 2012 First Six Months, an increase of $4.7 million, or 7.3%. Salaries and related costs for New Clinics amounted to $3.4 million for the 2013 First Six Months. Salaries and related costs for Mature Clinics increased by $1.4 million for the 2013 First Six Months as compared to the 2012 First Six Months. The increase in salaries and related costs for Mature Clinics is due to the results of the May 2012 Acquisition. The 2013 First Six Months includes six months of activity, and the 2012 First Six Months includes slightly over one month of activity, for the May 2012 Acquisition. Salaries and related costs as a percentage of net revenues were 53.9% for the 2013 First Six Months and 51.7% for the 2012 First Six Months.

Clinic Operating Costs - Rent, Clinic Supplies, Contract Labor and Other

Rent, clinic supplies, contract labor and other were $25.8 million for the 2013 First Six Months and $25.5 million for the 2012 First Six Months. For New Clinics, rent, clinic supplies, contract labor and other amounted to $1.4 million for the 2013 First Six Months. For Mature Clinics, rent, clinic supplies, contract labor and other decreased by $1.1 million in the 2013 First Six Months compared to the 2012 First Six Months. Rent, clinic supplies, contract labor and other as a percentage of net revenues was 19.8% for the 2013 First Six Months and 20.1% for the 2012 First Six Months.

Clinic Operating Costs - Provision for Doubtful Accounts

The provision for doubtful accounts was $2.3 million for the 2013 First Six Months and $2.4 million for the 2012 First Six Months. The provision for doubtful accounts for patient accounts receivable as a percentage of net patient revenues was 1.8% for the 2013 First Six Months and 2.0% for the 2012 First Six Months.

Our allowance for doubtful accounts for patient accounts receivable as a percentage of total patient accounts receivable was 5.1% at June 30, 2013, as compared to 5.8% at December 31, 2012. Our days sales outstanding was 40 days at June 30, 2013 and 42 days at December 31, 2012.

Gross Margin

The following table details the gross margin derived from our core physical therapy business and physician services business for the 2013 First Six Months and 2012 First Six Months (in thousands):

Six Months Ended June 30, 2013 2012
Gross margin - physical therapy services $32,437 $33,106
Gross margin - physician services (473) 21
Gross margin $31,964 $33,127

In the first quarter of 2013, we made a management change to oversee the Physician Services Business. In December 2012, we closed one of the OA Centers and will close the second location in late August 2013. We expect to incur approximately $50,000 in cost in August 2013 related to the OA Center closure. In the event that we are unsuccessful in returning the RMG part of the Physician Services Business to former levels of profitability, we may be required to write-down a portion of or all of the goodwill and other intangible assets associated with RMG. As of June 30, 2013, the goodwill and other intangible assets of RMG were valued at $6.4 million.

Corporate Office Costs

Corporate office costs, consisting primarily of salaries and benefits of corporate office personnel, rent, insurance costs, depreciation and amortization, travel, legal, professional, and recruiting fees, were $13.1 million for the 2013 First Six Months and $12.7 million for the 2012 First Six Months. As a percentage of net revenues, corporate office costs were 10.1% for the 2013 First Six Months and 10.0% for the 2012 First Six Months.

Interest Expense

Interest expense decreased to $265,000 in the 2013 First Six Months compared to $307,000 in the 2012 First Six Months due to a lower average outstanding balance under our Credit Agreement during the 2013 period compared to the 2012 period. At June 30, 2013, $15,750,000 was outstanding under our Credit Agreement.

Provision for Income Taxes

The provision for income taxes was $5.6 million for the 2013 First Six Months and $6.0 million for the 2012 First Six Months. During the 2013 and 2012 First Six Months, we accrued state and federal income taxes at an effective tax rate (provision for taxes divided by the difference between income before taxes and net income attributable to non-controlling interests) of 39.3%.

Non-controlling Interests

Net income attributable to non-controlling interests was $4.3 million for the 2013 First Six Months and $4.8 million for the 2012 First Six Months. Net income attributable to non-controlling interests as a percentage of operating income before corporate office costs was 13.6% for the 2013 First Six Months and 14.5% for the 2012 First Six Months. The decrease in the percentage is primarily due to the purchases of non-controlling interests in various partnerships during 2012 and 2013. During 2012, we purchased partnership interests in 15 separate partnerships which interest ranged from 10% to 35% and during the 2013 First Six Months, we purchased partnership interests in five separate partnerships which interest ranged from .1% to 35%.

LIQUIDITY AND CAPITAL RESOURCES

We believe that our business is generating sufficient cash flow from operations to allow us to meet our short-term and long-term cash requirements, other than those with respect to future acquisitions. At June 30, 2013, we had $10.3 million in cash compared to cash of $11.7 million at December 31, 2012. Although the start-up costs associated with opening new clinics and our planned capital expenditures are significant, we believe that our cash and unused availability under our $75.0 million Credit Agreement are sufficient to fund the working capital needs of our operating subsidiaries, corporate costs, dividends, purchases of our common stock, accrued clinic closure costs, future clinic development and investments through at least June 2014. Significant acquisitions of clinics and/or non-controlling interests would likely require financing under our Credit Agreement.

During the 2013 First Six Months, $20.7 million was provided by operations. The major uses of cash included: purchasees of businesses ($10.0 million), distributions to non-controlling interest partners ($4.4 million), purchases of fixed assets ($2.4 million), payments of cash dividends to our shareholders ($2.4 million), net pay down on our Credit Agreement ($1.7 million) and payments for acquisitions of non-controlling interests ($1.1 million).

Effective August 27, 2007, we entered into a credit agreement with a commitment for a $30.0 million revolving credit facility which was increased to $50.0 million effective June 4, 2008 and increased to $75.0 million effective July 14, 2011 (the “Credit Agreement”). Effective March 18, 2009, we amended the Credit Agreement to permit us to purchase up to $15,000,000 of our common stock subject to compliance with certain covenants, including the requirement that after giving effect to any stock purchase, our consolidated leverage ratio (as defined in the Credit Agreement) be less than 1.0 to 1.0 and that any stock repurchased be retired within seven days of purchase. Effective October 13, 2010, we amended the Credit Agreement to extend the maturity date from August 31, 2011 to August 31, 2015. In addition, the Credit Agreement was amended to adjust the pricing grid which is based on our consolidated leverage ratio with the applicable spread over LIBOR ranging from 1.6% to 2.5% or the applicable spread over the Base Rate ranging from .1% to 1%. Effective October 24, 2012, we amended the Credit Agreement to permit us to purchase, commencing on October 24, 2012 and at all times thereafter, up to $15,000,000 of our common stock subject to compliance with covenants. On December 3, 2012, we amended the Credit to allow the Company to pay a special dividend of $0.40 per share. The Credit Agreement is unsecured and has loan covenants, including requirements that the Company comply with a consolidated fixed charge coverage ratio and consolidated leverage ratio. The Credit Agreement is unsecured and has loan covenants, including requirements that we comply with a consolidated fixed charge coverage ratio and consolidated leverage ratio. Proceeds from the Credit Agreement may be used for working capital, acquisitions, purchases of our common stock, dividend payments to our common shareholders, capital expenditures and other corporate purposes. Fees under the Credit Agreement include an unused commitment fee ranging from .1% to .25% depending on our consolidated leverage ratio and the amount of funds outstanding under the Credit Agreement. On June 30, 2013, $15.8 million was outstanding under the Credit Agreement resulting in $59.2 million of availability, and we were in compliance with all of the covenants thereunder.

Historically, we have generated sufficient cash from operations to fund our development activities and to cover operational needs. We plan to continue developing new clinics and making additional acquisitions. We also from time to time purchase the non-controlling interests in our Clinic Partnerships. Generally, any acquisition or purchase of non-controlling interests is expected to be accomplished using a combination of cash and financing. Any large acquisition would likely require financing.

We make reasonable and appropriate efforts to collect accounts receivable, including applicable deductible and co-payment amounts, in a consistent manner for all payor types. Claims are submitted to payors daily, weekly or monthly in accordance with our policy or payor’s requirements. When possible, we submit our claims electronically. The collection process is time consuming and typically involves the submission of claims to multiple payors whose payment of claims may be dependent upon the payment of another payor. Claims under litigation and vehicular incidents can take a year or longer to collect. Medicare and other payor claims relating to new clinics awaiting Medicare Rehab Agency status approval initially may not be submitted for six months or more. When all reasonable internal collection efforts have been exhausted, accounts are written off prior to sending them to outside collection firms. With managed care, commercial health plans and self-pay payor type receivables, the write-off generally occurs after the account receivable has been outstanding for at least 120 days.

We generally enter into various notes payable as a means of financing a portion of the purchase price of our acquisitions. Our presently outstanding notes payable relate to acquisitions that occurred in 2013, 2012 and 2011. At June 30, 2013, the balance on these notes payable was $1,200,000.

In conjunction with acquisitions that occurred in 2010 through 2013, in the event that a limited minority partner’s employment ceases at any time after three years from the acquisition date, we have agreed to repurchase that individual’s non-controlling interest at a predetermined multiple of earnings before interest and taxes.

From September 2001 through December 31, 2008, our Board of Directors (“Board”) authorized us to purchase, in the open market or in privately negotiated transactions, up to 2,250,000 shares of our common stock. In March 2009, the Board authorized the repurchase of up to 10% or approximately 1,200,000 shares of our common stock (“March 2009 Authorization”). In connection with the March 2009 Authorization, we amended our bank credit agreement to permit share repurchases of up to $15,000,000. We are required to retire shares purchased under the March 2009 Authorization. Effective October 24, 2012, we amended the Credit Agreement to permit us to purchase, commencing on October 24, 2012 and at all times thereafter, up to $15,000,000 of our common stock subject to compliance with covenants.

There is no expiration date for the share repurchase program. As of June 30, 2013, there are currently an additional estimated 341,000 shares that may be purchased from time to time in the open market or private transactions depending on price, availability and our cash position. We did not purchase any shares of our common stock during the six months ended June 30, 2013.

FACTORS AFFECTING FUTURE RESULTS

The risks related to our business and operations include:

  • The uncertain economic conditions and the historically high unemployment rate in the United States may have material adverse impacts on our business and financial condition that we currently cannot predict.
  • We depend upon reimbursement by third-party payors including Medicare and Medicaid.
  • Changes as a result of healthcare reform legislation, and implementation thereof, may affect our business.
  • We depend upon the cultivation and maintenance of relationships with the physicians in our markets.
  • We also depend upon our ability to recruit and retain experienced physical and occupational therapists.
  • Our revenues may fluctuate due to weather.
  • Our operations are subject to extensive regulation.
  • We operate in a highly competitive industry.
  • We may incur closure costs and losses.
  • Future acquisitions may use significant resources, may be unsuccessful and could expose us to unforeseen liabilities.
  • Certain of our internal controls, particularly as they relate to billings and cash collections, are largely decentralized at our clinic locations.

See Risk Factors in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2012.

Forward-Looking Statements

We make statements in this report that are considered to be forward-looking within the meaning under Section 21E of the Securities Exchange Act of 1934. These statements contain forward-looking information relating to our financial condition, results of operations, plans, objectives, future performance and business. These statements (often using words such as “believes”, “expects”, “intends”, “plans”, “appear”, “should” and similar words) involve risks and uncertainties that could cause actual results to differ materially from those we project. Included among such statements are those relating to opening new clinics, availability of personnel and the reimbursement environment. The forward-looking statements are based on our current views and assumptions and actual results could differ materially from those anticipated in such forward-looking statements as a result of certain risks, uncertainties, and factors, which include, but are not limited to:

  • changes in Medicare guidelines and reimbursement or failure of our clinics to maintain their Medicare certification status,
  • revenue and earnings expectations;
  • general economic conditions;
  • business and regulatory conditions including federal and state regulations;
  • changes as the result of government enacted national healthcare reform;
  • availability and cost of qualified physical and occupational therapists;
  • personnel productivity;
  • competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain clinics and thereby incur losses and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets;
  • changes in reimbursement rates or payment methods from third party payors including government agencies and deductibles and co-pays owed by patients;
  • maintaining adequate internal controls;
  • availability, terms, and use of capital;
  • acquisitions, purchase of non-controlling interests (minority interests) and the successful integration of the operations of the acquired businesses; and
  • weather and other seasonal factors.

Many factors are beyond our control. Given these uncertainties, you should not place undue reliance on our forward-looking statements. Please see our periodic reports filed with the Securities and Exchange Commission (the “SEC”) for more information on these factors. Our forward-looking statements represent our estimates and assumptions only as of the date of this report. Except as required by law, we are under no obligation to update any forward-looking statement, regardless of the reason the statement is no longer accurate.

Market risk

As filed, 549 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We do not maintain any derivative instruments, interest rate swap arrangements, hedging contracts, futures contracts or the like. Our primary market risk exposure is the changes in interest rates obtainable on our Credit Agreement. The interest on our Credit Agreement is based on a variable rate. At June 30, 2013, $15.8 million was outstanding under our Credit Agreement. Based on the balance of the Credit Agreement at June 30, 2013, any change in the interest rate of 1% would yield a decrease or increase in annual interest expense of $157,500.

Controls and procedures

As filed, 1,386 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a) Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this report, the Company’s management completed an evaluation, under the supervision and with the participation of our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures. Based on this evaluation, our principal executive officer and principal financial officer concluded (i) that our disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure and (ii) that our disclosure controls and procedures are effective.

(b) Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-04-01 to 2013-06-30$67.2mus-gaap:SalesRevenueNet
Revenue6 months2013-01-01 to 2013-06-30$130.3mus-gaap:SalesRevenueNet
Gross profit3 months2013-04-01 to 2013-06-30$17.3mus-gaap:GrossProfit
Gross profit6 months2013-01-01 to 2013-06-30$32.0mus-gaap:GrossProfit
Operating income3 months2013-04-01 to 2013-06-30$10.7mus-gaap:OperatingIncomeLoss
Operating income6 months2013-01-01 to 2013-06-30$18.8mus-gaap:OperatingIncomeLoss
Interest expense3 months2013-04-01 to 2013-06-30$130.0kus-gaap:InterestExpense
Interest expense6 months2013-01-01 to 2013-06-30$265.0kus-gaap:InterestExpense
Income tax3 months2013-04-01 to 2013-06-30$3.2mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2013-01-01 to 2013-06-30$5.6mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-04-01 to 2013-06-30$4.9mus-gaap:NetIncomeLoss
Net income6 months2013-01-01 to 2013-06-30$8.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2013-04-01 to 2013-06-30$0.41us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2013-01-01 to 2013-06-30$0.72us-gaap:EarningsPerShareDiluted
Basic EPS3 months2013-04-01 to 2013-06-30$0.41us-gaap:EarningsPerShareBasic
Basic EPS6 months2013-01-01 to 2013-06-30$0.72us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2013-04-01 to 2013-06-3012,110,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2013-01-01 to 2013-06-3012,044,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2013-01-01 to 2013-06-30$20.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2013-01-01 to 2013-06-30$2.4mus-gaap:PaymentsToAcquireProductiveAssets
Dividends paid6 months2013-01-01 to 2013-06-30$2.4mus-gaap:PaymentsOfDividendsCommonStock
Cash and equivalentsAt period end2013-06-30$10.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-06-30$41.4mus-gaap:AssetsCurrent
Total assetsAt period end2013-06-30$182.4mus-gaap:Assets
Current liabilitiesAt period end2013-06-30$17.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-06-30$35.2mus-gaap:Liabilities
Long-term debtAt period end2013-06-30$16.1mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2013-06-30$800.0kus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2013-06-30$124.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-13-325579. Last ingested by Listed: Nov 14, 2026, 13:45 ET. Listed shows no prices and gives no investment advice.